Does BISOPROLOL Cause Hepatic lesion? 14 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Hepatic lesion have been filed in association with BISOPROLOL (bisoprolol fumarate and hydrochlorothiazide). This represents 0.1% of all adverse event reports for BISOPROLOL.
14
Reports of Hepatic lesion with BISOPROLOL
0.1%
of all BISOPROLOL reports
0
Deaths
11
Hospitalizations
How Dangerous Is Hepatic lesion From BISOPROLOL?
Of the 14 reports, 11 (78.6%) required hospitalization.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BISOPROLOL. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does BISOPROLOL Cause?
Dyspnoea (2,940)
Bradycardia (2,535)
Hypotension (2,504)
Dizziness (2,153)
Fall (2,011)
Fatigue (1,983)
Acute kidney injury (1,894)
Malaise (1,602)
Drug ineffective (1,486)
Nausea (1,460)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which BISOPROLOL Alternatives Have Lower Hepatic lesion Risk?
BISOPROLOL vs BISOPROLOL\BISOPROLOL
BISOPROLOL vs BISOPROLOL\HYDROCHLOROTHIAZIDE
BISOPROLOL vs BIVALIRUDIN
BISOPROLOL vs BLEOMYCIN
BISOPROLOL vs BLINATUMOMAB